Class - 10 Micro 2021
Class - 10 Micro 2021
Class - 10 Micro 2021
e__
___
___
___
_
Cl
ass10
_
___
___
___
___
___
___
___
___
___
___
___
_
_
___
___
___
___
___
___
___
___
___
___
___
_
_
___
___
___
___
___
___
___
___
___
___
___
_
_
___
___
___
___
___
___
___
___
___
___
___
_
_
___
___
___
___
___
___
___
___
___
___
___
_
_
___
___
___
___
___
___
___
___
___
___
___
_
_
___
___
___
___
___
___
___
___
___
___
___
__
2.Listthemai n st
agesoftheinfl
uenzavir
usrepr
oducti
vecy cl
eand it
s unique
featur
es.Expl
ainamechani
sm ofr
emantadi
neandosel
tamiv
iranti
vi
ral
acti
vi
ty.
_
___
___
___
___
___
___
___
___
___
___
___
_
_
___
___
___
___
___
___
___
___
___
___
___
_
_
___
___
___
___
___
___
___
___
___
___
___
_
_
___
___
___
___
___
___
___
___
___
___
___
_
_
___
___
___
___
___
___
___
___
___
___
___
_
_
___
___
___
___
___
___
___
___
___
___
___
_
_
___
___
___
___
___
___
___
___
___
___
___
_
_
___
___
___
___
___
___
___
___
___
___
___
_
_
___
___
___
___
___
___
___
___
___
___
___
_
___
___
___
___
___
___
___
___
___
___
___
___
_
___
___
___
___
___
___
___
___
___
___
___
___
_
_
___
___
___
___
___
___
___
___
___
___
___
___
_
_
___
___
___
___
___
___
___
___
___
___
___
___
3.Li
stmethodsusedforinfl
uenzavir
usculturi
ngandindi
cationofthevir
usincult
ure:
__
___
_____
_____
_____
_____
______
_____
____
__ _
____
___
_____
________
_____
_____
_
__
___
_____
_____
_____
_____
______
_____
____
__ _
____
___
_____
________
_____
_____
__
____
______
_____
_____
______
_____
_____
________
___
_______
__ _
_____
_____
_____
__
____
______
_____
_____
______
_____
_____
________
___
_______
__ _
_____
_____
_____
___
____
__
____
______
_____
_____
______
_____
_____
________
___
_______
__ _
_____
_____
_____
___
4.Runhemaggl uti
nat
iont
estwithal
lantoi
cfl
uidoft hechickenembry
oinf
ect
edwith
nasalwashingsofthei
nfl
uenzapati
entandincubated at37°Сfor72h.Readand
drawtheresult
.
1:
4 1:
8 1:
16 1:
32 1:
64 Cont
rol
-
NaCl0,
85%
Concl
usi
on:___
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
___
__
____
___
____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
5.Readandwri
tedowntheresul
toft hehemagglutinati
oni
nhibi
tiontest(
HItest)
,
perf
ormedwit
hthefort
hepatientsvir
usident
ifi
cationwit
h3t ypesofsera.
A)ant
i-
A/Cal
i
for
nia/7/
2009;B)anti
-A/Cali
for
nia/4/2009;C)anti
-A/Bri
sbane/59/
2007
6.Compl
eteaschemeofl
abor
ator
ydi
agnosi
sofi
nfl
uenza:
Speci
men:
_
___
___
___
___
met
hod _
___
___
___
___
___
___
_met
hod _
___
___
___
___
___
_met
hod
IFt
est 1.Vi
rusi
sol
ati
on:
(
toi
dent
if
y__
___
___
_) Deter
minati
onoft heAb
Chi
ckenembr
yo ti
ter
sinpair
edser a:
Cel
lcul
tur
e HIt est
PCR CFT
(
toi
dent
if
y___
___
__) ELISA
I
mmunochromatogr
aphy 2.Vi
rusdet
ect
ion:
(t
oident
if
y__
_____
__)
HAtest HAdst
est
3.Vir
usident
if
icat
ion:
HItest HadsIt
est
CFT
ELI
SA
7.Descri
beact ualt
ypeofant i
-i
nfl
uenzavacci
ne(quadri
val
entfl
u:A(H1N1)
,A(
H2N3),B
(y
amagat a),B(Vi
ctori
a)andgeneralschemesofit
smanuf act
uri
ng:
____
_____
_ _
__ _
____
_ _
_____
______
_____
_____
____
_____
_____
_____
____
____
___
___
___
___
___
____
_____
_ _
__ _
____
_ _
_____
______
_____
_____
____
_____
_____
_____
____
____
___
___
___
___
___
____
_____
_ _
__ _
____
_ _
_____
______
_____
_____
____
_____
_____
_____
____
____
___
___
___
___
___
____
_____
_ _
__ _
____
_ _
_____
______
_____
_____
____
__
8.Label
mai
nst
ruct
ural
element
soft
hemeasl
esv
iri
on.
_
___
___
___
___
___
___
___
___
___
___
___
_
_
___
___
___
___
___
___
___
___
___
___
___
_
_
___
___
___
___
___
___
___
___
___
___
___
_
_
___
___
___
___
___
___
___
___
___
___
___
_
_
___
___
___
___
___
___
___
___
___
___
___
_
_
___
___
___
___
___
___
___
___
___
___
___
_
_
___
___
___
___
___
___
___
___
___
___
___
__
9.Compl
eteaschemeoft
hepar
amy
xov
irusr
epr
oduct
ivecy
cleandl
i
sti
tsmai
nst
ages.
_
___
___
___
___
___
___
___
___
___
___
_
___
___
___
___
___
___
___
___
___
___
_
___
___
___
___
___
___
___
___
___
___
_
___
___
___
___
___
___
___
___
___
___
_
___
___
___
___
___
___
___
___
___
___
_
___
___
___
___
___
___
___
___
___
___
_
___
___
___
___
___
___
___
___
___
___
_
___
___
___
___
___
___
___
___
___
___
10.Li
stmet hodsusedf orparainfl
uenzaviruscult
uri
ngandi ndicati
onoft
hev
irusi
n
cul
ture::___
_____
_____
______
_ _
______
_______
____
____
_ _
___ _
_______
__
______
_ _
____
______
_____
_____
__ _
______
______
____
_____
_ _
___________
___
_________
______
_____
_____
_________
______
_ _
_____
_______
__ __
________
__
11.Compl eteaschemeofal aborator
ydiagnosisofparai
nfluenza.
Speci
men:
_
___
___
___
___
met
hod _
___
___
___
___
___
___
_met
hod _
___
___
___
___
___
_met
hod
IFtest 1.I
sol
ationofvir
us: Demonst
rati
onofAbi
n
(
Ident
if
icat
ionof ___
____
__ _
_____
_____ pai
redbl
oodseraby:
…………) ___
___
_______
______
____
___
__ CFT
I
Hads
PCR ELISA
(I
dent
if
icat
ion 2.Vir
usdetecti
on:__
_____
_
of…………) ___
_____
___
_ __
____
_____
_____
3.Vir
usident
ifi
cat
ion:
___
_____
_____
_____
_____
___
___
12.
Descr
ibepr
epar
ati
onsusedf
ort
hepr
ophy
laxi
sofpar
amy
xov
irusesi
nfect
ions:
MMR:__
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
___
___
___
___
___
__
___
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_
ISW:Adenov i
ruses.Laborator
ydiagnosisofadenovir
alinf
ecti
ons.
1.Generalcharacter
isti
candclassif
icati
onofadenovir
uses.
2.Str
uctureandr epl
icati
onofadenov i
ruses.
3.Pathogenesisofadenov i
rali
nfecti
ons.
4.Laborat
orydiagnosisofadenov i
ralinf
ecti
ons.
Teacher’
ssignat
ure_
___
___
___
___
___